Zakkiyya A Posey

A phase II study of everolimus (E) and sorafenib (S) in patients (PTS) with metastatic differentiated thyroid cancer who have progressed on sorafenib alone.

A. Troxel, M. Brose, M. Yarchoan, 2015 .

A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting

A. Troxel, M. Brose, M. Yarchoan, 2018 .